Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Strategic investments in science-backed ingredients, targeted product development, and collaborative research will be critical for brands seeking to stay relevant in this shifting landscape and capture the growing demand for GLP-1-aligned solutions
Heres what you should know about key states: States With No In-Person Requirements These states allow fully virtual care for GLP-1 prescriptions: California : Explicitly permits telehealth prescribing with no in-person requirements Connecticut : Has permanent telehealth laws with no in-person mandate Florida : Allows telehealth prescribing but requires follow-up every 3 months Illinois : Has robust telehealth laws with no in-person examination requirement New York : Telehealth exam is sufficient
In the drugs best showing so far, the ATTAIN-1 trial, people taking orforglipron lost on average 12.4% of their baseline weight, a notch below the roughly 14% weight loss seen in similar trials of Novo Nordisks injectable Wegovy and also below the typical results seen with Eli Lillys tirzepatide, a dual GLP-1/GIP medication
Its about learning how your body responds to treatment while maintaining good hydration, adequate protein intake, and healthy nutrition
US$ 20.91
US$ 25.06
US$ 23.99
US$ 26.61
US$ 26.17
US$ 27.63
